A 13-minute segment on a recent episode of CBS's 60 Minutes appeared to be a news story on Novo Nordisk's weight-loss drug Wegovy but was actually a sponsored promotion, violating federal regulations, according to the nonprofit public health advocacy organization Physicians Committee.The group filed a complaint with the Food and Drug Administration last week, arguing that the segment, which aired on January 1, violates the FDA's "fair balance" requirement.
[
add
]
[
|
|
...
]